GT BIOPHARMA, INC. Selling, General and Administrative Expense
GT BIOPHARMA, INC. (GTBP) reported Selling, General and Administrative Expense of $3.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- GT BIOPHARMA, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $3.46M, a 200.61% increase year-over-year.
- GT BIOPHARMA, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.44M, a 192.32% increase year-over-year.
- GT BIOPHARMA, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $4.22M, a 130.17% increase year-over-year.
- GT BIOPHARMA, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.75M, a 19.63% increase year-over-year.
- GT BIOPHARMA, INC. selling, general and administrative expense for fiscal 2025 was $8.95M, a 4.48% increase from fiscal 2024.
- GT BIOPHARMA, INC. selling, general and administrative expense for fiscal 2024 was $8.57M, a 20.48% increase from fiscal 2023.
- GT BIOPHARMA, INC. selling, general and administrative expense for fiscal 2023 was $7.11M, a 42.87% decline from fiscal 2022.
- GT BIOPHARMA, INC. selling, general and administrative expense for fiscal 2022 was $12.45M, a 74.03% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.46M 10-Q · filed 2026-08-14 | $5.89M 10-Q · filed 2026-08-14 | $10.11M derived: sum of 3 quarters · filed 2026-08-14 | $12.86M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $2.44M 10-Q · filed 2026-05-15 | $6.65M derived: sum of 2 quarters · filed 2026-05-15 | $9.40M derived: sum of 3 quarters · filed 2026-05-15 | $10.55M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $4.22M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | $6.97M derived: sum of 2 quarters · filed 2026-03-06 | $8.12M derived: sum of 3 quarters · filed 2026-08-14 | $8.95M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $2.75M 10-Q/A · filed 2026-03-06 | $3.90M derived: sum of 2 quarters · filed 2026-08-14 | $4.73M 10-Q/A · filed 2026-03-06 | $6.56M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $1.15M 10-Q · filed 2026-08-14 | $1.98M 10-Q · filed 2026-08-14 | $3.82M derived: sum of 3 quarters · filed 2026-08-14 | $6.11M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $833.00K 10-Q · filed 2026-05-15 | $2.67M derived: sum of 2 quarters · filed 2026-05-15 | $4.96M derived: sum of 3 quarters · filed 2026-05-15 | $7.08M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $1.83M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | $4.13M derived: sum of 2 quarters · filed 2026-03-06 | $6.25M derived: sum of 3 quarters · filed 2026-03-06 | $8.57M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $2.30M 10-Q/A · filed 2026-03-06 | $4.42M derived: sum of 2 quarters · filed 2026-03-06 | $6.73M 10-Q/A · filed 2026-03-06 | $8.54M derived: sum of 4 quarters · filed 2026-03-06 | |
| 2024-06-30 | $2.12M 10-Q/A · filed 2026-03-06 | $4.44M 10-Q/A · filed 2026-03-06 | $6.25M derived: sum of 3 quarters · filed 2026-03-06 | $8.01M derived: sum of 4 quarters · filed 2026-03-06 | |
| 2024-03-31 | $2.31M 10-Q · filed 2025-05-15 | $4.13M derived: sum of 2 quarters · filed 2025-05-15 | $5.88M derived: sum of 3 quarters · filed 2025-05-15 | $7.41M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $3.57M derived: sum of 2 quarters · filed 2025-02-21 | $5.09M derived: sum of 3 quarters · filed 2025-02-21 | $7.11M 10-K · filed 2025-02-21 | |
| 2023-09-30 | $1.76M 10-Q · filed 2024-11-14 | $3.28M derived: sum of 2 quarters · filed 2024-11-14 | $5.30M 10-Q · filed 2024-11-14 | $8.23M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $1.53M 10-Q · filed 2024-08-14 | $3.54M 10-Q · filed 2024-08-14 | $6.48M derived: sum of 3 quarters · filed 2024-08-14 | $10.76M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $2.02M 10-Q · filed 2024-05-15 | $4.95M derived: sum of 2 quarters · filed 2024-05-15 | $9.23M derived: sum of 3 quarters · filed 2024-05-15 | $11.11M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $7.22M derived: sum of 2 quarters · filed 2024-03-26 | $9.09M derived: sum of 3 quarters · filed 2024-03-26 | $12.45M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $4.28M 10-Q · filed 2023-11-01 | $6.16M derived: sum of 2 quarters · filed 2023-11-01 | $9.51M 10-Q · filed 2023-11-01 | $21.38M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2022-06-30 | $1.88M 10-Q · filed 2023-08-07 | $5.23M 10-Q · filed 2023-08-07 | $17.10M derived: sum of 3 quarters · filed 2023-08-07 | $22.05M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $3.35M 10-Q · filed 2023-05-15 | $15.23M derived: sum of 2 quarters · filed 2023-05-15 | $20.18M derived: sum of 3 quarters · filed 2023-05-15 | $23.92M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $16.82M derived: sum of 2 quarters · filed 2023-03-30 | $20.56M derived: sum of 3 quarters · filed 2023-03-30 | $47.92M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $4.95M 10-Q · filed 2022-10-31 | $8.69M derived: sum of 2 quarters · filed 2022-10-31 | $36.05M 10-Q · filed 2022-10-31 | $38.01M derived: sum of 4 quarters · filed 2022-10-31 | |
| 2021-06-30 | $3.74M 10-Q · filed 2022-08-15 | $31.10M 10-Q · filed 2022-08-15 | $33.06M derived: sum of 3 quarters · filed 2022-08-15 | $35.09M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $27.36M 10-Q · filed 2022-05-16 | $29.32M derived: sum of 2 quarters · filed 2022-05-16 | $31.35M derived: sum of 3 quarters · filed 2022-05-16 | $32.90M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $3.99M derived: sum of 2 quarters · filed 2022-03-28 | $5.53M derived: sum of 3 quarters · filed 2022-03-28 | $6.28M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $2.03M 10-Q · filed 2021-11-10 | $3.58M derived: sum of 2 quarters · filed 2021-12-29 | $4.32M 10-Q · filed 2021-11-10 | $5.18M derived: sum of 4 quarters · filed 2021-12-29 | |
| 2020-06-30 | $1.55M 10-Q/A · filed 2021-12-29 | $2.29M 10-Q/A · filed 2021-12-29 | $3.15M derived: sum of 3 quarters · filed 2021-12-29 | $6.74M derived: sum of 4 quarters · filed 2021-12-29 | |
| 2020-03-31 | $746.00K 10-Q · filed 2021-05-17 | $1.60M derived: sum of 2 quarters · filed 2021-05-17 | $5.19M derived: sum of 3 quarters · filed 2021-05-17 | $7.31M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $858.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | $4.44M derived: sum of 2 quarters · filed 2021-04-16 | $6.57M derived: sum of 3 quarters · filed 2021-04-16 | $9.79M 10-K · filed 2021-04-16 | |
| 2019-09-30 | $3.58M 10-Q · filed 2020-11-13 | $5.71M derived: sum of 2 quarters · filed 2020-11-13 | $8.93M 10-Q · filed 2020-11-13 | $10.79M derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-06-30 | $2.13M 10-Q/A · filed 2020-08-18 | $5.35M 10-Q/A · filed 2020-08-18 | $7.21M derived: sum of 3 quarters · filed 2020-08-18 | $12.24M derived: sum of 4 quarters · filed 2020-08-18 | |
| 2019-03-31 | $3.22M 10-Q · filed 2020-05-15 | $5.08M derived: sum of 2 quarters · filed 2020-05-15 | $10.12M derived: sum of 3 quarters · filed 2020-05-15 | $12.02M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $6.89M derived: sum of 2 quarters · filed 2020-03-27 | $8.80M derived: sum of 3 quarters · filed 2020-03-27 | $12.49M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $5.04M 10-Q · filed 2019-11-14 | $6.94M derived: sum of 2 quarters · filed 2019-11-14 | $10.63M 10-Q · filed 2019-11-14 | $16.36M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $1.91M 10-Q · filed 2019-08-14 | $5.59M 10-Q · filed 2019-08-14 | $11.33M derived: sum of 3 quarters · filed 2019-08-14 | $137.66M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $3.69M 10-Q · filed 2019-05-15 | $9.42M derived: sum of 2 quarters · filed 2019-05-15 | $135.75M derived: sum of 3 quarters · filed 2019-05-15 | $136.79M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $132.06M derived: sum of 2 quarters · filed 2019-03-29 | $133.11M derived: sum of 3 quarters · filed 2019-03-29 | $134.50M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $126.33M 10-Q · filed 2018-11-14 | $127.37M derived: sum of 2 quarters · filed 2018-11-14 | $128.77M 10-Q · filed 2018-11-14 | $129.34M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $1.04M 10-Q · filed 2018-08-14 | $2.44M 10-Q · filed 2018-08-14 | $3.01M derived: sum of 3 quarters · filed 2018-08-14 | $5.29M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $1.39M 10-Q · filed 2018-05-15 | $1.97M derived: sum of 2 quarters · filed 2018-05-15 | $4.25M derived: sum of 3 quarters · filed 2018-05-15 | $6.12M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $572.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $2.85M derived: sum of 2 quarters · filed 2018-03-01 | $4.72M derived: sum of 3 quarters · filed 2018-03-01 | $8.40M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $2.28M 10-Q/A · filed 2018-02-28 | $4.15M derived: sum of 2 quarters · filed 2018-02-28 | $7.83M 10-Q/A · filed 2018-02-28 | $10.21M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $1.87M 10-Q/A · filed 2018-02-28 | $5.55M 10-Q/A · filed 2018-02-28 | $7.93M derived: sum of 3 quarters · filed 2018-02-28 | $10.48M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $3.68M 10-Q/A · filed 2018-02-28 | $6.06M derived: sum of 2 quarters · filed 2018-02-28 | $8.61M derived: sum of 3 quarters · filed 2018-02-28 | $10.06M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $2.38M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | $4.93M derived: sum of 2 quarters · filed 2018-02-28 | $6.39M derived: sum of 3 quarters · filed 2018-02-28 | $7.95M 10-K/A · filed 2018-02-28 | |
| 2015-09-30 | $2.55M 10-Q/A · filed 2018-02-28 | $4.00M derived: sum of 2 quarters · filed 2018-02-28 | $5.57M 10-Q/A · filed 2018-02-28 | $7.21M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-06-30 | $1.45M 10-Q/A · filed 2018-02-28 | $3.02M 10-Q/A · filed 2018-02-28 | $4.66M derived: sum of 3 quarters · filed 2018-02-28 | $5.21M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-03-31 | $1.57M 10-Q/A · filed 2018-02-28 | $3.21M derived: sum of 2 quarters · filed 2018-02-28 | $3.75M derived: sum of 3 quarters · filed 2018-02-28 | $3.87M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2014-12-31 | $1.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $2.19M derived: sum of 2 quarters · filed 2018-02-28 | $2.30M derived: sum of 3 quarters · filed 2018-02-28 | $2.40M 10-K/A · filed 2018-02-28 | |
| 2014-09-30 | $547.00K 10-Q · filed 2015-11-13 | $659.00K derived: sum of 2 quarters · filed 2015-11-13 | $760.00K 10-Q · filed 2015-11-13 | $1.01M derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $112.00K 10-Q · filed 2015-08-14 | $213.00K 10-Q · filed 2015-08-14 | $464.00K derived: sum of 3 quarters · filed 2015-08-14 | $664.00K derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | $101.00K 10-Q · filed 2015-05-14 | $352.00K derived: sum of 2 quarters · filed 2015-05-14 | $552.00K derived: sum of 3 quarters · filed 2015-05-14 | $670.00K derived: sum of 4 quarters · filed 2015-05-14 | |
| 2013-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $451.00K derived: sum of 2 quarters · filed 2015-03-31 | $569.00K derived: sum of 3 quarters · filed 2015-03-31 | $935.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $200.00K 10-Q · filed 2014-12-17 | $318.00K derived: sum of 2 quarters · filed 2015-01-08 | $684.00K 10-Q · filed 2015-01-08 | $1.18M derived: sum of 4 quarters · filed 2015-01-08 | |
| 2013-06-30 | $118.00K 10-Q · filed 2015-01-08 | $484.00K 10-Q · filed 2015-01-08 | $981.00K derived: sum of 3 quarters · filed 2015-01-08 | $2.42M derived: sum of 4 quarters · filed 2015-01-08 | |
| 2013-03-31 | $366.00K 10-Q · filed 2015-01-08 | $863.00K derived: sum of 2 quarters · filed 2015-01-08 | $2.30M derived: sum of 3 quarters · filed 2015-01-08 | $3.33M derived: sum of 4 quarters · filed 2015-01-08 | |
| 2012-12-31 | $497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | $1.94M derived: sum of 2 quarters · filed 2015-01-08 | $2.97M derived: sum of 3 quarters · filed 2015-01-08 | $3.36M 10-K · filed 2015-01-08 | |
| 2012-09-30 | $1.44M 10-Q · filed 2014-12-17 | $2.47M derived: sum of 2 quarters · filed 2014-12-17 | $2.87M 10-Q · filed 2014-12-17 | $3.53M derived: sum of 4 quarters · filed 2014-12-17 | |
| 2012-06-30 | $1.03M 10-Q · filed 2014-12-12 | $1.43M 10-Q · filed 2014-12-12 | $2.09M derived: sum of 3 quarters · filed 2014-12-12 | $2.63M derived: sum of 4 quarters · filed 2014-12-12 | |
| 2012-03-31 | $397.00K 10-Q · filed 2014-12-10 | $396.00K 10-Q · filed 2012-05-21 | $1.06M derived: sum of 2 quarters · filed 2014-12-10 | $1.59M derived: sum of 3 quarters · filed 2014-12-10 | $2.03M derived: sum of 4 quarters · filed 2014-12-10 |
| 2011-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $1.20M derived: sum of 2 quarters · filed 2014-11-18 | $1.64M derived: sum of 3 quarters · filed 2014-11-18 | $3.47M 10-K · filed 2014-11-18 | |
| 2011-09-30 | $535.00K 10-Q · filed 2012-11-21 | $974.00K derived: sum of 2 quarters · filed 2012-11-21 | $2.81M 10-Q · filed 2012-11-21 | $3.26M derived: sum of 4 quarters · filed 2012-11-21 | |
| 2011-06-30 | $439.00K 10-Q/A · filed 2012-09-13 | $2.27M 10-Q/A · filed 2012-09-13 | $2.73M derived: sum of 3 quarters · filed 2012-09-13 | $3.31M derived: sum of 4 quarters · filed 2012-09-13 | |
| 2011-03-31 | $1.83M 10-Q · filed 2012-05-21 | $2.29M derived: sum of 2 quarters · filed 2012-05-21 | $2.87M derived: sum of 3 quarters · filed 2012-05-21 | $3.17M derived: sum of 4 quarters · filed 2012-05-21 | |
| 2010-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $1.04M derived: sum of 2 quarters · filed 2012-04-16 | $1.34M derived: sum of 3 quarters · filed 2012-04-16 | $2.26M 10-K · filed 2012-04-16 | |
| 2010-09-30 | $588.00K 10-Q · filed 2011-11-21 | $885.00K derived: sum of 2 quarters · filed 2011-11-21 | $1.81M 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $297.00K 10-Q/A · filed 2011-09-12 | $1.22M 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |